GLSIGreenwich LifeSciences, Inc.

Nasdaq greenwichlifesciences.com


$ 14.54 $ 1.13 (8.45 %)    

Friday, 06-Sep-2024 15:58:35 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 14.5
$ 14.50 x 100
-- x --
-- - --
$ 7.58 - $ 21.44
142,753
na
190.6M
$ 0.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-15-2024 12-31-2023 10-K
4 10-19-2023 09-30-2023 10-Q
5 08-21-2023 06-30-2023 10-Q
6 05-22-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-20-2022 03-31-2022 10-Q
11 03-21-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-20-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-greenwich-lifesciences-raises-price-target-to-38

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price targe...

 greenwich-lifesciences-provides-update-of-expansion-of-clinical-sites-into-spain-says-30-out-of-38-sites-have-conducted-site-initiation-visits-to-date

In the coming months, partner GEICAM hopes to complete the remaining SIVs and the Company hopes to visit the remaining sites.

 greenwich-lifesciences-to-join-russell-2000-and-3000-indexes-in-july

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

 greenwich-lifesciences-announces-private-placement-of-25m-at-1430-per-share-closing-expected-on-or-about-june-18-2024

The company announced that it has entered into a securities purchase agreement with its Chief Executive Officer, Snehal Patel, ...

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-36-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...

 insiders-buying-greenwich-lifesciences-and-2-other-stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-36-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...

 greenwich-lifesciences-flamingo-01-phase-3-trial-which-is-evaluating-glsi-100-an-immunotherapy-to-prevent-breast-cancer-recurrences-approved-to-expand-into-five-largest-european-countries

The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, an...

 greenwich-lifesciences-flamingo-01-manufacturing--protocol-accepted-by-european-regulators

The Company was informed that the manufacturing, non-clinical, clinical, statistical, and regulatory sections of its applicatio...

 hc-wainwright--co-maintains-buy-on-greenwich-lifesciences-lowers-price-target-to-36

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targe...

 why-greenwich-lifesciences-glsi-stock-is-skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III ...

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 369 companies set new 52-week lows.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-lowers-price-target-to-38

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION